Compare Enveric Biosciences Inc (ENVB) vs Revvity Inc (RVTY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Enveric Biosciences Inc vs Revvity Inc — how do they compare? Enveric Biosciences Inc trades at $1.45 (market cap $6.20M), while Revvity Inc trades at $115.76 (market cap $12.91B). The key difference: Revvity Inc is far larger — about 2082.3× Enveric Biosciences Inc's market cap, and Revvity Inc pays a 0.24% dividend while Enveric Biosciences Inc pays none. Which is the better fit depends on your goals.
| ENVB | RVTY | |
|---|---|---|
Market Cap | $6.20M | $12.91B |
Sector | Health | Technology |
52-Week High | $17.40 | $117.75 |
52-Week Low | $1.27 | $82.26 |
Enterprise Value | $1.30M | $15.23B |
Dividend Yield | — | 0.24% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Enveric Biosciences Inc
Enveric Biosciences is a biotechnology company focused on developing next-generation psychedelic-inspired therapies for mental health and neuropsychiatric disorders.
Read more on ENVB →About Revvity Inc
Revvity, Inc., formerly the Life Sciences and Diagnostics businesses of PerkinElmer, is a global provider of scientific and diagnostic solutions. The company focuses on the health and wellness of humanity through its expertise in life science research, detection, imaging, and informatics. Revvity supplies a broad portfolio of instruments, reagents, and services to pharmaceutical companies, academic research institutions, and clinical laboratories worldwide, enabling customers to make advancements in human health.
Read more on RVTY →
